PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17520061-3	2007	We have previously shown that trivalent metabolites of iAs, arsenite (iAs(III)) and methylarsonous acid (MAs(III)) inhibit insulin-stimulated glucose uptake (ISGU) in 3T3-L1 adipocytes by suppressing the insulin-dependent phosphorylation of protein kinase B (PKB/Akt).	4-Iodoacetamidosalicylic acid	55-58	AKT serine/threonine kinase 1	Homo sapiens	259-262	
17520061-3	2007	We have previously shown that trivalent metabolites of iAs, arsenite (iAs(III)) and methylarsonous acid (MAs(III)) inhibit insulin-stimulated glucose uptake (ISGU) in 3T3-L1 adipocytes by suppressing the insulin-dependent phosphorylation of protein kinase B (PKB/Akt).	4-Iodoacetamidosalicylic acid	55-58	AKT serine/threonine kinase 1	Homo sapiens	263-266	
17520061-3	2007	We have previously shown that trivalent metabolites of iAs, arsenite (iAs(III)) and methylarsonous acid (MAs(III)) inhibit insulin-stimulated glucose uptake (ISGU) in 3T3-L1 adipocytes by suppressing the insulin-dependent phosphorylation of protein kinase B (PKB/Akt).	4-Iodoacetamidosalicylic acid	70-73	AKT serine/threonine kinase 1	Homo sapiens	259-262	
17520061-3	2007	We have previously shown that trivalent metabolites of iAs, arsenite (iAs(III)) and methylarsonous acid (MAs(III)) inhibit insulin-stimulated glucose uptake (ISGU) in 3T3-L1 adipocytes by suppressing the insulin-dependent phosphorylation of protein kinase B (PKB/Akt).	4-Iodoacetamidosalicylic acid	70-73	AKT serine/threonine kinase 1	Homo sapiens	263-266